Hyaluronic Acid Viscosupplementation Market Size, Share, and Trends Analysis | Global | 2025-2031 | MedCore | Includes: Single Injection Market, Two Injection Market, and 2 more

  • Year: 2025
  • Scope: 10 Years
  • Region: Global
  • Published Date: 01/24/2025
  • Type: MedCore

Product Description

The global hyaluronic acid viscosupplementation market was valued at $2.5 billion in 2024. This is expected to increase over the forecast period at a CAGR of 2.9% to reach $3 billion.

The full report suite on the global market for hyaluronic acid (HA) viscosupplementation includes single injection, two injections, three injections and five injections.

This report includes data for 65 countries across 7 different regions. These regions are North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.

DATA TYPES INCLUDED

  • Unit Sales, Average Selling Prices, Market Size & Growth Trends
  • Procedure Numbers
  • Market Drivers & Limiters
  • Market Forecasts Until 2031, and Historical Data to 2021
  • Recent Mergers & Acquisitions
  • Company Profiles and Product Portfolios
  • Leading Competitors

GLOBAL HYALURONIC ACID VISCOSUPPLEMENTATION MARKET INSIGHTS

Global Hyaluronic Acid Viscosupplementation Market InsightsThe HA viscosupplementation market experienced a notable decline in sales due to the COVID-19 pandemic. The primary driver was the widespread cancellation and postponement of elective surgeries, which significantly disrupted the industry’s ecosystem. While this downturn was temporary, the impact in 2020 was substantial, with many companies incurring unprecedented losses. However, the market demonstrated resilience and managed to recover notably by 2022, returning to its trajectory of steady growth.

GLOBAL HYALURONIC ACID VISCOSUPPLEMENTATION MARKET SHARE INSIGHTSTop Global Hyaluronic Viscosupplementation Market Leaders

  • DePuy Synthes was the leader of the HA viscosupplementation market due to the success of both MONOVISC® single-injection and ORTHOVISC® three-injection products.
  • Fidia held the second-leading position in the HA viscosupplementation market by offering its two-injection product HYMOVIS®.
  • Sanofi was the third-leading competitor in the HA viscosupplementation market in 2024. The company competes with its products Synvisc® and Synvisc-One®, benefiting from the rising cases of osteoarthritis and an aging population.

GLOBAL HYALURONIC ACID VISCOSUPPLEMENTATION MARKET SEGMENTATION SUMMARY

  • Single Injection Market
  • Two Injections Market
  • Three Injections Market
  • Five Injections Market

RESEARCH SCOPE SUMMARY

Report Attribute Details
Regions North America(Canada, United States)
Latin America(Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela)
Western Europe(Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom)
Central & Eastern Europe(Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine)
Middle East(Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates)
Asia Pacific(Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam)
Africa(Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year 2024
Forecast 2025-2031
Historical Data 2021-2023
Quantitative Coverage Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

 

FREE Sample Report

7.1 Executive Summary
7.1.2 Competitive Analysis
7.1.3 Regions Included
7.2 Introduction
7.2.1 Benefits of Viscosupplementation
7.2.2 Synovial Fluid
7.2.3 Product Types
7.2.3.1 Single-Injection Products
7.2.3.2 Two-Injection Cycle Products
7.2.3.3 Three-Injection Cycle Products
7.2.3.4 Three-/Five-Injection Cycle Products
7.3 Procedure Numbers
7.4 Market Overview
7.4.1 By Segment
7.4.2 By Region
7.5 Market Analysis and Forecast
7.5.1 Total Hyaluronic Acid Viscosupplementation Market
7.5.2 Single-Injection Hyaluronic Acid Viscosupplementation Market
7.5.3 Two-Injection Hyaluronic Acid Viscosupplementation Market
7.5.4 Three-Injection Hyaluronic Acid Viscosupplementation Market
7.5.5 Five-Injection Hyaluronic Acid Viscosupplementation Market
7.6 Drivers and Limiters
7.6.1 Market Drivers
7.6.2 Market Limiters
7.7 Competitive Market Share Analysis
·         AbbVie ·         LCA Pharma
·         Acumed ·         LifeLink Tissue Bank
·         AlloSource ·         LifeNet Health
·         Alphatec Spine ·         Meda Pharma
·         Anika Therapeutics ·         Medtronic
·         Arthrex ·         MTF
·         B. Braun Melsungen ·         Novabone
·         Baxter ·         Nuo Therapeutics
·         Berkeley Advanced Biomaterials ·         Octane Medical
·         Biocell ·         Orthocell Ltd.
·         Biocomposites ·         OrthogenRx
·         Biogennix ·         Orthofix
·         Bioiberica ·         Osteogenics
·         Biomatlante ·         OsteoMed
·         Biotissue Technologies ·         Paragon 28
·         Bioventus ·         Plasmaconcept
·         Bonalive ·         PromoCell
·         Celling Biosciences ·         Rebone Biomaterials
·         Cerapedics ·         Recordati
·         Cingal ·         Regenexx
·         Croma-Pharma ·         Regenity Biosciences
·         CO.DON GmbH ·         RTI Surgical
·         CONMED ·         Sanofi
·         Curasan ·         Sartorius CellGenix GmbH
·         DCI Donor Services ·         Seikagaku
·         DePuy Synthes ·         Smith & Nephew
·         Documedica ·         Solvita
·         Elutia Inc. ·         Spinal Elements
·         Exactech ·         Stella Pharmaceuticals
·         Ferring Pharmaceuticals ·         Stryker
·         Fidia ·         Takara Bio
·         Finceramica ·         Tedec-Meiji
·         Geistlich ·         Terumo
·         Globus Medical/NuVasive ·         Teva Pharmaceutical
·         Hanmi Pharmaceutical ·         ThermoGenesis
·         Healiva ·         TRB Chemedica
·         IBSA Pharma ·         Viatris
·         Integra LifeSciences ·         Vericel
·         Isto Biologics ·         Vivex
·         Kolon Tissuegene ·         Xtant Medical
·         Kuros ·         Zimmer Biomet
Chart 7‑1: Hyaluronic Acid Viscosupplementation Market, Global, 2024 & 2031
Chart 7‑2: Hyaluronic Acid Viscosupplementation Procedures, Global, 2024
Chart 7‑3: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Region, Global, 2021 – 2031
Chart 7‑4: Hyaluronic Acid Viscosupplementation Device Market by Segment, Global, 2021 – 2031
Chart 7‑5: Hyaluronic Acid Viscosupplementation Device Market by Region, Global, 2021 – 2031
Chart 7‑6: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Global, 2024
Figure 7‑1: Hyaluronic Acid Viscosupplementation Regions Covered, Global (1 of 2)
Figure 7‑2: Hyaluronic Acid Viscosupplementation Regions Covered, Global (2 of 2)
Figure 7‑3: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Region, Global, 2021 – 2031
Figure 7‑4: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, North America, 2021 – 2031
Figure 7‑5: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Latin America, 2021 – 2031 (1 of 2)
Figure 7‑6: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Latin America, 2021 – 2031 (2 of 2)
Figure 7‑7: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Western Europe, 2021 – 2031
Figure 7‑8: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Central & Eastern Europe, 2021 – 2031 (1 of 2)
Figure 7‑9: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Central & Eastern Europe, 2021 – 2031 (2 of 2)
Figure 7‑10: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Middle East, 2021 – 2031
Figure 7‑11: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Asia-Pacific, 2021 – 2031 (1 of 3)
Figure 7‑12: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Asia-Pacific, 2021 – 2031 (2 of 3)
Figure 7‑13: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Asia-Pacific, 2021 – 2031 (3 of 3)
Figure 7‑14: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Africa, 2021 – 2031
Figure 7‑15: Hyaluronic Acid Viscosupplementation Device Market by Segment, Global, 2021 – 2031 (US$M)
Figure 7‑16: Hyaluronic Acid Viscosupplementation Device Market by Region, Global, 2021 – 2031 (US$M)
Figure 7‑17: Hyaluronic Acid Viscosupplementation Market, Global, 2021 – 2031
Figure 7‑18: Units Sold by Region, Hyaluronic Acid Viscosupplementation Market, Global, 2021 – 2031
Figure 7‑19: Average Selling Price by Region, Hyaluronic Acid Viscosupplementation Market, Global, 2021 – 2031 (US$)
Figure 7‑20: Market Value by Region, Hyaluronic Acid Viscosupplementation Market, Global, 2021 – 2031 (US$M)
Figure 7‑21: Single-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 – 2031
Figure 7‑22: Units Sold by Region, Single-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 – 2031
Figure 7‑23: Average Selling Price by Region, Single-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 – 2031 (US$)
Figure 7‑24: Market Value by Region, Single-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 – 2031 (US$M)
Figure 7‑25: Two-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 – 2031
Figure 7‑26: Units Sold by Region, Two-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 – 2031
Figure 7‑27: Average Selling Price by Region, Two-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 – 2031 (US$)
Figure 7‑28: Market Value by Region, Two-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 – 2031 (US$M)
Figure 7‑29: Three-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 – 2031
Figure 7‑30: Units Sold by Region, Three-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 – 2031
Figure 7‑31: Average Selling Price by Region, Three-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 – 2031 (US$)
Figure 7‑32: Market Value by Region, Three-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 – 2031 (US$M)
Figure 7‑33: Five-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 – 2031
Figure 7‑34: Units Sold by Region, Five-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 – 2031
Figure 7‑35: Average Selling Price by Region, Five-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021– 2031 (US$)
Figure 7‑36: Market Value by Region, Five-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 – 2031 (US$M)
Figure 7‑37: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Global, 2024

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Options

Report Summary

FREE

Select License Type

  • 2025
  • 10 Years
  • Global
  • 01/24/2025
  • MedCore
0
    0
    Your Cart
    Your cart is emptyReturn to Report Library